Table 1 Description of the population based patient material
All | Ductal | Lobular | Tubular | Medullary | Mucinous | Other | |
|---|---|---|---|---|---|---|---|
Age at diagnosis: median(range) | 56 (23-89) | 58 (24-89) | 60 (30-84) | 55 (35-79) | 52 (31-77) | 59 (36-79) | 55 (23-87) |
N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
Number of cases: | 1676 | 695 (41) | 141 (8) | 43 (3) | 27 (2) | 25 (1) | 745 (44) |
Age at diagnosis: | |||||||
20-39 | 147 (9) | 57 (8) | 7 (5) | 4 (9) | 4 (15) | 2 (8) | 73 (10) |
40-59 | 848 (51) | 336 (48) | 62 (44) | 23 (53) | 13 (48) | 10 (40) | 404 (54) |
60-69 | 422 (25) | 175 (25) | 49 (35) | 12 (28) | 6 (22) | 8 (32) | 172 (23) |
70-89 | 258 (15) | 127 (18) | 23 (16) | 4 (9) | 4 (15) | 5 (20) | 95 (13) |
Cancer in 1° relatives: | |||||||
No family history of cancer | 700 (42) | 279 (40) | 52 (37) | 19 (44) | 13 (48) | 12 (48) | 325 (44) |
Child | 20 (1) | 13 (2) | 0 (0) | 1 (2) | 0 (0) | 0 (0) | 8 (1) |
Brother | 83 (5) | 47 (7) | 10 (7) | 0 (0) | 0 (0) | 3 (12) | 23 (3) |
Sister: | |||||||
-all diagnoses | 213 (13) | 88 (13) | 23 (16) | 9 (21) | 4 (15) | 2 (8) | 87 (12) |
-not including bc | 115 (7) | 49 (7) | 10 (7) | 3 (7) | 3 (11) | 1 (4) | 49 (7) |
Father: | 257 (15) | 121 (17) | 38 (27) | 7 (16) | 2 (7) | 4 (16) | 151 0) |
- Prostate | 67 (4) | 28 (4) | 8 (6) | 2 (5) | 1 (4) | 2 (8) | 26 (3) |
Mother: | |||||||
- all diagnoses | 357 (21) | 178 (26) | 34 (24) | 5 (12) | 3 (11) | 5 (20) | 152 (20) |
- not including bc | 219 (13) | 116 (17) | 19 (13) | 4 (9) | 3 (11) | 1 (4) | 92 (12) |
Unknown family history | 13 (1) | 8 (1) | 1 (1) | 0 (0) | 0 (0) | 0 (0) | 4 (1) |
Family history of bc: | |||||||
No family history of bc | 1131 (67) | 465 (67) | 93 (66) | 28 (65) | 20 (74) | 18 (72) | 507 (68) |
Vertical family history | 381 (23) | 162 (23) | 30 (21) | 8 (19) | 5 (19) | 5 (20) | 171 (23) |
Horizontal family history | 84 (5) | 33 (5) | 11 (8) | 7 (16) | 0 (0) | 1 (4) | 32 (4) |
Cousin family history | 67 (4) | 27 (4) | 6 (4) | 0 (0) | 2 (7) | 1 (4) | 31 (4) |
Ever-use of HRT: | 328 (19) | 137 (20) | 39 (28) | 12 (28) | 4 (15) | 3 (12) | 133 (18) |
Hormone receptor status: | |||||||
ER-positive | 744 (44) | 352 (51) | 90 (64) | 13 (30) | 1 (4) | 13 (52) | 275 (37) |
ER-negative | 351 (21) | 154 (22) | 14 (10) | 6 (14) | 16 (59) | 5 (20) | 156 (21) |
ER-unknown | 581 (35) | 189 (27) | 37 (26) | 24 (56) | 10 (37) | 7 (28) | 314 (42) |
PR-positive | 611 (36) | 294 (42) | 70 (50) | 10 (23) | 2 (7) | 9 (36) | 226 (30) |
PR-negative | 446 (27) | 196 (28) | 32 (23) | 9 (21) | 15 (56) | 9 (36) | 185 (25) |
PR-unknown | 619 (37) | 205 (30) | 39 (27) | 24 (56) | 10 (37) | 7 (28) | 334 (45) |